Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Prostatic Blood Flow in BPH
NCT01152190Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tadalafil in benign prostatic hyperplasia (BPH), sponsored by Eli Lilly and Company. Started Sep 2010; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01152190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152190.